Careers article - February 3, 2026
Elekta is reducing the number of employees by 450
At Elekta's Strategic Update for investors the company announced that, as a consequence of the company’s new operating model, it is reducing the number of employees by 450.
Biotech Business - February 2, 2026
Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand
Alvotech has entered into supply and commercialization agreements with Sandoz covering multiple biosimilar candidates in Canada, and in Australia and New Zealand.
Clinical Trials - February 2, 2026
SynAct Pharma initiates Phase 2 study in respiratory insufficiency
SynAct Pharma has initiated a Phase 2 study (RESPIRE) with resomelagon in patients hospitalized with respiratory insufficiency due to viral infections.
Agreement - January 30, 2026
Bavarian Nordic signs distribution agreement with Eurofarma
Bavarian Nordic has announced an agreement with Eurofarma, granting them exclusive rights to sell and distribute Bavarian Nordic’s chikungunya vaccine, CHIKV VLP, in Brazil.
Science News - January 30, 2026
AI: Fewer missed cancer cases in breast cancer screening
The final results from Lund University's MASAI trial are now available.
Global report - January 30, 2026
AstraZeneca enhances its weight management portfolio
AstraZeneca has entered a new strategic collaboration agreement with CSPC Pharmaceuticals to advance the development of multiple next-generation therapies for obesity and type 2 diabetes across eight programmes.
